A Phase I study to evaluate the safety and dosimetry of 68Ga-labelled OncoFAP derivatives in patients with solid tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500902-16-00

Acronym

PH-FAPGA-01/22

Enrollment

Registered

2022-11-09

Start date

2023-04-27

Completion date

2024-04-26

Last updated

2024-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer, oesophageal cancer and pancreatic adenocarcinoma., Patients with breast cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026